Nukkleus [NUKKW] vs Salesforce [CRM] Detailed Stock Comparison
Nukkleus
NASDAQ
Loading...
Salesforce
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Nukkleus wins in 6 metrics, Salesforce wins in 7 metrics, with 0 ties. Salesforce appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Nukkleus | Salesforce | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 34.94 | N/A |
| Price-to-Book Ratio | N/A | 3.74 | N/A |
| Debt-to-Equity Ratio | -0.04 | 19.26 | Nukkleus |
| PEG Ratio | N/A | 1.06 | N/A |
| EV/EBITDA | -264.19 | 19.73 | Nukkleus |
| Profit Margin (TTM) | 16.89% | 16.87% | Nukkleus |
| Operating Margin (TTM) | -134.75% | 22.82% | Salesforce |
| EBITDA Margin (TTM) | N/A | 22.82% | N/A |
| Return on Equity | 120.02% | 11.20% | Nukkleus |
| Return on Assets (TTM) | -864.83% | 5.52% | Salesforce |
| Free Cash Flow (TTM) | $-3.82M | $12.43B | Salesforce |
| Dividend Yield | N/A | 0.62% | N/A |
| 1-Year Return | 500.00% | -14.69% | Nukkleus |
| Price-to-Sales Ratio (TTM) | 339.75 | 5.79 | Salesforce |
| Enterprise Value | $2.01B | $225.26B | Salesforce |
| EV/Revenue Ratio | 340.43 | 5.70 | Salesforce |
| Gross Profit Margin (TTM) | N/A | 78.10% | N/A |
| Revenue per Share (TTM) | N/A | $41 | N/A |
| Earnings per Share (Diluted) | $-0.02 | $6.88 | Salesforce |
| Beta (Stock Volatility) | -6.29 | 1.20 | Nukkleus |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Nukkleus vs Salesforce Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Nukkleus | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Salesforce | 2.25% | 0.28% | -2.57% | -8.90% | 0.64% | -25.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Nukkleus | 500.00% | 38.46% | 38.46% | 38.46% | 38.46% | 38.46% |
| Salesforce | -14.69% | 72.82% | -4.94% | 212.02% | 807.27% | 4,328.47% |
News Based Sentiment: Nukkleus vs Salesforce
Nukkleus
News based Sentiment: MIXED
October was a month of significant swings for Nukkleus Inc. warrants (NUKKW), with a large initial price increase followed by a decline, but strong overall returns. The leadership change at Vocodia adds a layer of complexity and potential strategic impact, making this a noteworthy month for investors.
Salesforce
News based Sentiment: MIXED
Salesforce delivered strong Q2 and Q3 results, raising guidance and expanding partnerships, but faced user backlash regarding Agentforce and initial market volatility. The mixed analyst reactions and insider trading activity add complexity to the overall investment picture, making it a significant but not overwhelmingly positive month.
Performance & Financial Health Analysis: Nukkleus vs Salesforce
| Metric | NUKKW | CRM |
|---|---|---|
| Market Information | ||
| Market Cap | $2.01B | $236.34B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 154,058 | 7,873,910 |
| 90 Day Avg. Volume | 248,108 | 9,660,590 |
| Last Close | $0.03 | $245.78 |
| 52 Week Range | $0.03 - $0.03 | $226.48 - $369.00 |
| % from 52W High | 0.00% | -33.39% |
| All-Time High | $0.21 (Aug 26, 2025) | $369.00 (Dec 02, 2024) |
| % from All-Time High | -85.71% | -33.39% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.10% |
| Quarterly Earnings Growth | -1.00% | 0.32% |
| Financial Health | ||
| Profit Margin (TTM) | 0.17% | 0.17% |
| Operating Margin (TTM) | -1.35% | 0.23% |
| Return on Equity (TTM) | 1.20% | 0.11% |
| Debt to Equity (MRQ) | -0.04 | 19.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-9.94 | $64.22 |
| Cash per Share (MRQ) | $0.22 | $16.15 |
| Operating Cash Flow (TTM) | $-2,233,552 | $13.17B |
| Levered Free Cash Flow (TTM) | $-8,518,520 | $13.90B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.62% |
| Last 12-Month Dividend | N/A | $1.62 |
Valuation & Enterprise Metrics Analysis: Nukkleus vs Salesforce
| Metric | NUKKW | CRM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 34.94 |
| Forward P/E | N/A | 21.60 |
| PEG Ratio | N/A | 1.06 |
| Price to Sales (TTM) | 339.75 | 5.79 |
| Price to Book (MRQ) | N/A | 3.74 |
| Market Capitalization | ||
| Market Capitalization | $2.01B | $236.34B |
| Enterprise Value | $2.01B | $225.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 340.43 | 5.70 |
| Enterprise to EBITDA | -264.19 | 19.73 |
| Risk & Other Metrics | ||
| Beta | -6.29 | 1.20 |
| Book Value per Share (MRQ) | $-9.94 | $64.22 |
Financial Statements Comparison: Nukkleus vs Salesforce
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NUKKW | CRM |
|---|---|---|
| Revenue/Sales | $0 | $10.24B |
| Cost of Goods Sold | $0 | $2.24B |
| Gross Profit | $0 | $7.99B |
| Research & Development | N/A | $1.48B |
| Operating Income (EBIT) | $-1.51M | $2.34B |
| EBITDA | $-1.51M | $3.15B |
| Pre-Tax Income | $103.14M | $2.41B |
| Income Tax | $0 | $519.00M |
| Net Income (Profit) | $102.96M | $1.89B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NUKKW | CRM |
|---|---|---|
| Cash & Equivalents | $4.46M | $10.93B |
| Total Current Assets | $8.46M | $25.87B |
| Total Current Liabilities | $64.71M | $24.20B |
| Long-Term Debt | $1.01M | $10.78B |
| Total Shareholders Equity | $-57.22M | $60.67B |
| Retained Earnings | $-98.12M | $17.50B |
| Property, Plant & Equipment | $127,328 | $5.26B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NUKKW | CRM |
|---|---|---|
| Operating Cash Flow | $103.44M | $6.89B |
| Capital Expenditures | $-10,221 | N/A |
| Free Cash Flow | $-1.35M | $6.30B |
| Debt Repayment | N/A | $-179.00M |
| Common Stock Repurchase | N/A | $-2.63B |
Short Interest & Institutional Ownership Analysis
| Metric | NUKKW | CRM |
|---|---|---|
| Shares Short | 8,328 | 13.05M |
| Short Ratio | N/A | 1.27 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 154,058 | 7,873,910 |
| Average Daily Volume (90 Day) | 248,108 | 9,660,590 |
| Shares Outstanding | 2.10M | 962.00M |
| Float Shares | 4.33M | 926.65M |
| % Held by Insiders | N/A | 0.03% |
| % Held by Institutions | N/A | 0.83% |
Dividend Analysis & Yield Comparison: Nukkleus vs Salesforce
| Metric | NUKKW | CRM |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.62 |
| Last 12-Month Dividend Yield | N/A | 0.62% |
| 3-Year Avg Annual Dividend | N/A | $0.67 |
| 3-Year Avg Dividend Yield | N/A | 0.15% |
| 3-Year Total Dividends | N/A | $2.02 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |